Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements - Contingent Consideration (Details)

v3.23.3
Fair Value Measurements - Contingent Consideration (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2023
Jun. 21, 2023
Dec. 31, 2022
Feb. 25, 2019
Fair Value Measurements          
Changes in estimated fair value of contingent consideration   $ 75      
Contingent consideration under RPAs, AAAs and CPPAs $ 4,000 4,000   $ 75  
Bioasis | Royalty Purchase Agreement          
Fair Value Measurements          
Contingent consideration under RPAs, AAAs and CPPAs 0 $ 0   $ 75 $ 75
LadRx | Royalty Purchase Agreement          
Fair Value Measurements          
Changes in estimated fair value of contingent consideration $ 0        
Contingent consideration under RPAs, AAAs and CPPAs     $ 1,000